Glaucoma News

Viridian Shares Rise on Thyroid Eye Disease Trial Data

Viridian Shares Rise on Thyroid Eye Disease Trial Data

Viridian Shares Surge on Strong Thyroid Eye Disease Trial Data A Promising Leap Forward in TED Treatment The biotechnology sector recently saw a notable rise in investor confidence as Viridian Therapeutics’ shares climbed sharply following encouraging clinical trial results. The latest data reinforces the company’s competitive position in the rapidly evolving thyroid eye disease (TED) […]

Viridian Shares Rise on Thyroid Eye Disease Trial Data Read More »

Can a Small Rival Challenge Amgen’s Eye Disease Drug

Can a Small Rival Challenge Amgen’s Eye Disease Drug?

Viridian Therapeutics Takes Aim at Amgen’s Eye Disease Blockbuster The biotechnology landscape is witnessing a high-stakes showdown in the rare disease space. Viridian Therapeutics, a clinical-stage biotech company, is positioning itself to challenge Amgen’s flagship franchise, Tepezza—the only FDA-approved treatment for Thyroid Eye Disease (TED). With a novel approach and encouraging early clinical data, Viridian

Can a Small Rival Challenge Amgen’s Eye Disease Drug? Read More »

6-Year-Old Receives Eye Gene Therapy for Rare Disorder

6-Year-Old Receives Eye Gene Therapy for Rare Disorder

6-Year-Old Girl Sees After Life-Changing Eye Gene Therapy A groundbreaking moment in pediatric ophthalmology — a 6-year-old girl born with a rare inherited retinal condition has experienced the miracle of sight for the first time following an innovative gene therapy procedure. This remarkable case represents not just a personal victory for one family, but a

6-Year-Old Receives Eye Gene Therapy for Rare Disorder Read More »

ASG-Eye-Hospital-Drives-Retinoblastoma-Awareness-Campaign

ASG Eye Hospital Drives Retinoblastoma Awareness Campaign

ASG Eye Hospital Highlights Retinoblastoma Awareness for Early Detection Saves Vision Understanding Retinoblastoma: Why Early Detection Can Save a Child’s Sight In a world where pediatric health is increasingly prioritized, one silent threat continues to affect children under the age of five: retinoblastoma. This rare but aggressive form of eye cancer originates in the retina

ASG Eye Hospital Drives Retinoblastoma Awareness Campaign Read More »

Sight Loss Tool Forecasts Surge in Eye Disease Cases

Sight Loss Tool Forecasts Surge in Eye Disease Cases

New Eye Disease Prediction Tool Warns of Rising Sight Loss Crisis The global landscape of vision health is shifting—and not in a direction that ophthalmologists or public health officials had hoped for. A groundbreaking new sight loss prediction tool has just published alarming data, forecasting a steep and previously underestimated rise in the number of

Sight Loss Tool Forecasts Surge in Eye Disease Cases Read More »

Scroll to Top